ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,251.33
      1.27%
      Dow Jones
      40,415.44
      0.32%
      Brent Oil
      81.655
      0.17%
      Bitcoin
      66,588.62
      -1.50%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. iTeos Therapeutics Inc (ITOS)

      7. iTeos Therapeutics Inc (ITOS) Financials

      iTeos Therapeutics Inc

      iTeos Therapeutics Inc (ITOS)

      NASDAQ
      16.30
      0.57
      (3.62%)
      Closed July 23 4:00PM
      Delayed by 15 minutes
      16.30
      0.00
      (0.00%)
      After Hours: 3:50PM
      Delayed by 15 minutes

      iTeos Therapeutics Inc Financial Summary

      The current ITOS market cap is 588.8M. The company's latest EPS is USD -3.1183 and P/E is -5.23.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 12.6M0000
      Operating Income -24.93M-42.75M-43.28M-40.15M-47.23M
      Net Income -15.55M-34.3M-32.24M-30.55M-38.22M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00344.78M267.63M12.6M
      Operating Income -28.05M-45.24M244.9M126.32M-151.1M
      Net Income -26.54M-43.4M214.52M96.65M-112.64M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 728.35M703.75M677.64M667.59M629.77M
      Total Liabilities 76.08M80.22M79.38M92.36M88.57M
      Total Equity 652.26M623.53M598.26M575.23M541.2M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 30.74M344.56M884.71M754.99M667.59M
      Total Liabilities 15.08M21.36M331.89M91.66M92.36M
      Total Equity -36.09M323.2M552.82M663.33M575.23M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -26.56M-56.1M-85.09M-103.76M-32.4M
      Investing -31.69M-11.59M11.1M72.66M-69.6M
      Financing 578k796k806k1.11M22k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -23.15M-25.18M513.14M-111.19M-103.76M
      Investing -926k-377k-1.24M-446.06M72.66M
      Financing 22.54M340.34M3.66M1.98M1.11M

      Stats and Ratios

      Market Cap 588.8M
      Price to Earnings Ratio -5.23
      Price to Sales Ratio 46.75
      Price to Cash Ratio 2.34
      Price to Book Ratio 1.02
      Dividend Yield -

      Share Statistics

      Shares Outstanding 36.12M
      Average Volume (1 week) 295.28k
      Average Volume (1 Month) 334.57k
      52 Week Change 11.80%
      52 Week High 18.75
      52 Week Low 8.20
      Spread (Intraday) 0.12 (0.73%)

      Company Info

      Company Name iTeos Therapeutics Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.iteostherapeutics.com
      Industry biological pds,ex diagnstics (2836)